Semnur Pharmaceuticals, Inc. Deferred Compensation Equity
Semnur Pharmaceuticals, Inc. (SMNR) had Deferred Compensation Equity of $2.02 million as of 2023-11-20, per its 10-Q filed 2024-05-22.
Discontinued › Balance Sheet › Equity
us-gaap:DeferredCompensationEquity · last filed 2024-05-22
- 2023-11-20: Deferred Compensation Equity $2.02M.
| Period end | Deferred Compensation Equity |
|---|---|
| 2023-11-20 | $2.02M 10-Q · filed 2024-05-22 |